BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31447973)

  • 21. The safety of available and emerging options for emergency contraception.
    Lee JK; Schwarz EB
    Expert Opin Drug Saf; 2017 Oct; 16(10):1163-1171. PubMed ID: 28730840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of bodyweight/body mass index on the effectiveness of emergency contraception with levonorgestrel: a pooled-analysis of three randomized controlled trials.
    Gemzell-Danielsson K; Kardos L; von Hertzen H
    Curr Med Res Opin; 2015 Dec; 31(12):2241-8. PubMed ID: 26368848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaginal bleeding following the use of a single dose of 1.5mg levonorgestrel (LNG) for emergency contraception.
    Arowojolu AO; Okewole IA
    West Afr J Med; 2004; 23(3):191-3. PubMed ID: 15587826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ulipristal acetate: review of the efficacy and safety of a newly approved agent for emergency contraception.
    Richardson AR; Maltz FN
    Clin Ther; 2012 Jan; 34(1):24-36. PubMed ID: 22154199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interventions for emergency contraception.
    Cheng L; Che Y; Gülmezoglu AM
    Cochrane Database Syst Rev; 2012 Aug; (8):CD001324. PubMed ID: 22895920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.
    Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium
    Lancet; 2019 Jul; 394(10195):303-313. PubMed ID: 31204114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Systematic Review and Meta-analysis of the Adverse Effects of Levonorgestrel Emergency Oral Contraceptive.
    Leelakanok N; Methaneethorn J
    Clin Drug Investig; 2020 May; 40(5):395-420. PubMed ID: 32162237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contraceptive Use and the Risk of Ectopic Pregnancy: A Multi-Center Case-Control Study.
    Li C; Zhao WH; Meng CX; Ping H; Qin GJ; Cao SJ; Xi X; Zhu Q; Li XC; Zhang J
    PLoS One; 2014; 9(12):e115031. PubMed ID: 25493939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.
    Heinemann K; Reed S; Moehner S; Minh TD
    Contraception; 2015 Apr; 91(4):280-3. PubMed ID: 25601350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
    Luukkainen T; Toivonen J
    Contraception; 1995 Nov; 52(5):269-76. PubMed ID: 8585882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergency contraception: a review.
    Haspels AA
    Contraception; 1994 Aug; 50(2):101-8. PubMed ID: 7956209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Counseling and in-advance provision of levonorgestrel emergency contraceptive pills decrease the rate of unplanned pregnancy during breastfeeding: a randomized controlled trial.
    Shaaban OM; Abbas AM; Mahmoud HR; Yones EM; Hassen SG; Zakherah MS
    J Matern Fetal Neonatal Med; 2019 Apr; 32(8):1250-1255. PubMed ID: 29117764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of levonorgestrel emergency contraception given before or after ovulation--a pilot study.
    Novikova N; Weisberg E; Stanczyk FZ; Croxatto HB; Fraser IS
    Contraception; 2007 Feb; 75(2):112-8. PubMed ID: 17241840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population-based evaluation of the effectiveness of two regimens for emergency contraception.
    Leung VW; Soon JA; Lynd LD; Marra CA; Levine M
    Int J Gynaecol Obstet; 2016 Jun; 133(3):342-6. PubMed ID: 26969148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
    Coutinho EM; de Souza JC; da Silva AR; de Acosta OM; Alvarez F; Brache V; Garza Flores J; Vasquez-Estrada L; Santo R; Bassol S
    Clin Pharmacol Ther; 1993 Jan; 53(1):65-75. PubMed ID: 8422744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls.
    Bahamondes L; Brache V; Meirik O; Ali M; Habib N; Landoulsi S;
    Hum Reprod; 2015 Nov; 30(11):2527-38. PubMed ID: 26409014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emergency contraception: which is the best?
    Mittal S
    Minerva Ginecol; 2016 Dec; 68(6):687-99. PubMed ID: 27082029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergency contraception with a copper IUD or oral levonorgestrel: an observational study of 1-year pregnancy rates.
    Turok DK; Jacobson JC; Dermish AI; Simonsen SE; Gurtcheff S; McFadden M; Murphy PA
    Contraception; 2014 Mar; 89(3):222-8. PubMed ID: 24332433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized clinical trial of two emergency contraceptive pill regimens in a Ugandan population.
    Byamugisha JK; Mirembe FM; Faxelid E; Tumwesigye NM; Gemzell-Danielsson K
    Acta Obstet Gynecol Scand; 2010 May; 89(5):670-6. PubMed ID: 20423278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Phase III, single-arm study of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5mg) in postmenarcheal adolescents.
    Gemzell-Danielsson K; Buhling KJ; Dermout SM; Lukkari-Lax E; Montegriffo E; Apter D
    Contraception; 2016 Jun; 93(6):507-12. PubMed ID: 26872720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.